Introduction
Following the patent expiries of angiotensin-II receptor blockers Datamonitor expects antihypertensives sales in the seven major markets to record sales of $29.5 billion in 2018, a drop of over $6 billion compared to 2008.
Reasons to Purchase
*Quantify the future size of the antihypertensives market and identify opportunities for new products.
*Learn how recent changes related to product expiries will shape the antihypertensives market.
*Understand the barriers to uptake for novel antihypertensive agents, and the need for paradigm shift in clinical trial design.
Other selected research from the 'Markets' category:
Partneringreview 2006 - Industry sector (volume 6)
The Biofuels Market 2010-2020
The Biofuels Market 2010-2020 is our brand new renewable energy report which outlines trends in the flourishing biofuels industry and anticipates the direction of the market over the next decade... Learn More